Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan
NCT00249977
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumors
Cancer
Interventions
DRUG:
Capecitabine in Combination with Cisplatin and Irinotecan
Sponsor
University of New Mexico